Home Visit
Upload
Flow For T-ALL MRD
Also known as: MRD Leukemia Panel - (T-ALL) by Flow Cytometry, EDTA Bone Marrow**
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Flow for T ALL MRD (Minimal Residual Disease) is a diagnostic test with clinical utility in the assessment of minimal residual disease in T-cell acute lymphoblastic leukemia (T-ALL) patients. Minimal residual disease refers to the small number of leukemic cells that remain in the body after treatment. Flow cytometry, a technique that uses fluorescently labeled antibodies, is employed to analyze and quantify these residual leukemic cells in the bone marrow or peripheral blood. The detection and monitoring of MRD are crucial in evaluating treatment response, predicting relapse, and guiding further therapeutic interventions. By assessing the level of MRD using flow cytometry, healthcare professionals can determine the effectiveness of treatment and make informed decisions regarding therapy adjustments, aiming to achieve and maintain minimal levels of residual disease. The Flow for T-ALL MRD test plays a vital role in the management of T-ALL patients, assisting in treatment decisions and optimizing long-term outcomes.
MRD Leukemia Panel - (T-ALL) by Flow Cytometry, EDTA Bone Marrow** Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the MRD Leukemia Panel - (T-ALL) by Flow Cytometry, EDTA Bone Marrow** with a clear pricing structure.
The MRD Leukemia Panel - (T-ALL) by Flow Cytometry, EDTA Bone Marrow** Price in Mumbai is ₹ 19,825 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The T-ALL MRD Test analyze and quantify residual leukemic cells in the bone marrow or peripheral blood in patients with T-cell acute lymphoblastic leukaemia (T-ALL).
• To monitor treatment effectiveness in patients with T-ALL • To detect MRD after treatment • To assess the risk of disease recurrence
The T-ALL MRD Test is recommended for patients with T-ALL.
If the T-ALL MRD Test results are abnormal, it may indicate residual cancer cells or a higher risk of disease recurrence.
During the test, a sample of bone marrow is collected using a needle. The sample is sent to the laboratory for analysis using flow cytometry.
• Inform your doctor about any medications or supplements you are taking. Also, tell them if you have any specific requirements. • Provide your medical history and any relevant hemato-pathological reports to your doctor • Follow any additional instructions given by your doctor.
• Hemato-pathological reports: To provide a comprehensive understanding of the disease and monitor treatment response • Genetic testing: To identify specific genetic abnormalities associated with T-ALL
Minimal residual disease test for T-cell acute lymphoblastic leukaemia (T-ALL)
T-cell acute lymphoblastic leukaemia (T-ALL) is a type of blood cancer that affects immature T-cells. It is characterised by an overproduction of abnormal T-cells in the bone marrow.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp